Class action suit targets Novartis

Share this article:
A US judge has ruled that Novartis Pharmaceuticals will have to defend itself against sex-discrimination claims brought by a group of female sales reps in a $100 million class-action lawsuit.

Judge Gerald Lynch granted class-action status to a lawsuit in US District Court in Manhattan against Novartis by 19 current and former sales employees.

The lawsuit, filed in 2004, alleged Novartis' pharma unit was discriminatory in its pay, promotions, evaluations and treatment of women who take pregnancy leave. About 5,000 women are believed to qualify as plaintiffs.

A Novartis spokesman said in published reports at press time that lawyers were still reviewing related documents.  

Share this article:

Email Newsletters

More in News

AstraZenca beefs up respiratory portfolio

AstraZenca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.

Amgen Q2 sales rise, company to lay off up to 2,900

Amgen Q2 sales rise, company to lay off ...

The majority of the layoffs will be in the US.

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...